Kexing Pharmaceuticals introduced the product Sorafenib tosylate, which has been approved by the Egyptian Drug Administration.

On September 1st, according to Kexing Pharmaceuticals, the company's imported product Sorafenib Tosylate Tablets has been approved for market by the Egyptian Drug Authority. Sorafenib, as a globally renowned molecular targeted drug, has been widely used in the treatment of various tumors such as liver cancer and kidney cancer since the original drug was approved for market by the FDA in December 2005.